Page 18 - அமெரிக்கன் சமூகம் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Johnson & Johnson COVID-19 vaccine, which requires just one shot, is on track to become third allowed for use in US Karen Weintraub, USA TODAY Replay Video UP NEXT A government advisory committee is likely to give a thumbs up Friday to a third COVID-19 vaccine, paving the way to increased supply of the much-in-demand vaccines. The new vaccine, from drugmaker Johnson & Johnson, offers a few advantages over the two that have been administered to 45 million Americans since mid-December, although it may be somewhat less effective. The J&J vaccine requires only one shot; the others, from Pfizer-BioNTech and Moderna, need two. It can be kept refrigerated rather than frozen for longer, making it easier to distribute through doctors offices and rural outposts. And it may cause fewer side effects.

South africaUnited statesAnna legreid doppJesse goodmanJulie moritaAnthony fauciJoe bidenLos angelesColleen kraftEric schneiderCenters for diseaseCommonwealth fundGeorgetown university medical centerAmerican society of healthDrug administrationVaccine analysis team